Related Articles
Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer
Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway
Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer
High levels of DEPDC1B predict shorter biochemical recurrence‑free survival of patients with prostate cancer